StockData
Abivax S.A. logo

Abivax S.A. (ABVX) stock

ABVXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as AAVXF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 1/30
$83.83+1.73 (+2.11%)

Close on Nov 18, 2026Market cap $6.58BP/E –Yield –

Abivax gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Abivax

Abivax has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Abivax figures

See a number that looks wrong?